4//SEC Filing
Omega Fund V, L.P. 4
Accession 0001209191-20-055046
CIK 0001741830other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 3:58 PM ET
Size
24.6 KB
Accession
0001209191-20-055046
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Omega Fund V, L.P.
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying) - Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying)
Omega Fund V GP, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying) - Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total - Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying)
Omega Fund V GP Manager, Ltd.
10% Owner
Transactions
- Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying) - Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying) - Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total
Nessi Claudio
10% Owner
Transactions
- Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total - Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying) - Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying)
Stampacchia Otello
Director
Transactions
- Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying) - Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total - Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying)
Paster Anne-Mari
10% Owner
Transactions
- Conversion
Common Stock
2020-10-14+1,376,313→ 3,001,984 total - Conversion
Common Stock
2020-10-14$16.15/sh+366,299$5,915,729→ 3,368,283 total - Purchase
Common Stock
2020-10-14$19.00/sh+450,000$8,550,000→ 3,818,283 total - Conversion
Series A Preferred Stock
2020-10-14−1,304,563→ 0 total→ Common Stock (1,376,313 underlying) - Conversion
Common Stock
2020-10-14+1,606,220→ 1,625,671 total - Conversion
Series Seed Preferred Stock
2020-10-14−1,522,484→ 0 total→ Common Stock (1,606,220 underlying) - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (366,299 underlying)
Footnotes (3)
- [F1]Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]Otello Stampacchia, a director of the Issuer, Claudio Nessi and Anne-Mari Paster are the directors of Omega Fund V GP Manager, Ltd. ("Omega Manager"), which is the sole general partner of Omega V Fund GP, L.P. ("Omega GP"), which is the sole general partner of Omega Fund V, L.P. ("Omega L.P."). Such individuals may be deemed to share voting and dispositive power over the shares held by Omega L.P. Such individuals, together with Omega GP and Omega Manager, disclaim beneficial ownership of the shares held by Omega L.P. except to the extent of their respective pecuniary interests therein.
- [F3]The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001641354
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 3:58 PM ET
- Size
- 24.6 KB